MANINA, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 652
EU - Europa 478
AS - Asia 291
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 1.427
Nazione #
US - Stati Uniti d'America 633
CN - Cina 259
IE - Irlanda 149
UA - Ucraina 90
DE - Germania 68
FI - Finlandia 54
SE - Svezia 46
IT - Italia 31
GB - Regno Unito 26
SG - Singapore 24
CA - Canada 19
FR - Francia 7
AU - Australia 3
BE - Belgio 2
BR - Brasile 2
IN - India 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
ES - Italia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
MU - Mauritius 1
RS - Serbia 1
Totale 1.427
Città #
Chandler 167
Dublin 149
Jacksonville 103
Nanjing 67
Ashburn 57
Beijing 49
Boardman 40
Wilmington 25
Jiaxing 21
Nanchang 21
Princeton 21
Changsha 19
Lawrence 19
Medford 19
Singapore 18
Tianjin 17
Helsinki 16
Ottawa 16
Hebei 14
Munich 14
Shanghai 14
Shenyang 13
Ann Arbor 11
Falls Church 10
New York 10
Los Angeles 9
Pavia 9
Hangzhou 8
Woodbridge 8
Verona 6
Norwalk 5
Milan 4
Piscataway 3
San Francisco 3
Brussels 2
Kunming 2
Melbourne 2
Redwood City 2
San Genesio ed Uniti 2
Toronto 2
Washington 2
Aleksinac 1
Amman 1
Auburn Hills 1
Bishkek 1
Changchun 1
Des Moines 1
Dubai 1
Fairfield 1
Falkenstein 1
Fuzhou 1
Guangzhou 1
Guntur 1
Gunzenhausen 1
Houston 1
Huntington 1
Hyderabad 1
Izhevsk 1
Lanzhou 1
Madrid 1
Mississauga 1
Newark 1
Perm 1
Riga 1
Rockville 1
Seattle 1
Seoul 1
Shiraz 1
Sydney 1
Taizhou 1
Tel Aviv 1
Totale 1.029
Nome #
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system 90
Decaprenylphosphoryl-β-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target 86
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 86
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 85
AN EFFECTIVE NEW DRUG TARGET FOR THE TREATMENT OF TUBERCULOSIS 83
Identification of cellular targets of new antitubercular drugs. 82
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 77
Azole drug resistance in Mycobacterium tuberculosis 75
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 75
NITROREDUCTASE NfnB FROM Mycobacterium smegmatis 74
Characterization of the mechanism of resistance to BM212, a new potential antitubercular drug. 74
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. 72
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 69
Identification and characterization of the cellular target for benzothiazinones, a new potential antitubercular drug class. 68
Identification of the cellular target of the potential antitubercular drug BM 212 65
Role in benzothiazinone resistance of nitroreductase NfnB of Mycobacterium smegmatis 61
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 61
Rv3790 is the cellular target for benzothiazinones, a new promising antitubercular drug class 57
Study of antibiotic efflux pumps belonging to Resistance-Nodulation-Division (RND) family in Burkholderia cenocepacia. 52
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis. 50
Totale 1.442
Categoria #
all - tutte 5.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 0 0 16 1 27 2 48 31 1
2020/2021174 21 14 7 17 0 24 0 24 7 25 28 7
2021/2022106 0 1 1 0 7 6 6 6 5 3 15 56
2022/2023424 34 44 1 40 44 40 0 36 169 2 11 3
2023/2024152 14 21 7 13 7 41 2 25 1 8 6 7
2024/202583 4 23 11 12 28 5 0 0 0 0 0 0
Totale 1.442